These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8869462)

  • 41. Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.
    Barrow RT; Healey JF; Gailani D; Scandella D; Lollar P
    Blood; 2000 Jan; 95(2):564-8. PubMed ID: 10627463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.
    Prescott R; Nakai H; Saenko EL; Scharrer I; Nilsson IM; Humphries JE; Hurst D; Bray G; Scandella D
    Blood; 1997 May; 89(10):3663-71. PubMed ID: 9160671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvements in factor VIII inhibitor detection: From Bethesda to Nijmegen.
    Verbruggen B; van Heerde WL; Laros-van Gorkom BA
    Semin Thromb Hemost; 2009 Nov; 35(8):752-9. PubMed ID: 20169511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization.
    Scandella D; Mattingly M; de Graaf S; Fulcher CA
    Blood; 1989 Oct; 74(5):1618-26. PubMed ID: 2477082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
    Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
    Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
    Sakurai Y; Shima M; Tanaka I; Fukuda K; Yoshida K; Yoshioka A
    Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
    Kessel C; Königs C; Linde R; Escuriola-Ettinghausen C; Stoll H; Klingebiel T; Dietrich U; Kreuz W
    Mol Immunol; 2008 Nov; 46(1):8-15. PubMed ID: 18715645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations: is it of clinical importance?
    Berntorp E
    Haematologica; 2003 Jun; 88(6):EREP03. PubMed ID: 12826529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effect.
    Nogami K; Shima M; Nakai H; Tanaka I; Suzuki H; Morichika S; Shibata M; Saenko EL; Scandella D; Giddings JC; Yoshioka A
    Br J Haematol; 1999 Oct; 107(1):196-203. PubMed ID: 10520041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. von Willebrand factor and transforming growth factor-beta modulate immune response against coagulation factor VIII in FVIII-deficient mice.
    Kallas A; Kuuse S; Maimets T; Pooga M
    Thromb Res; 2007; 120(6):911-9. PubMed ID: 17376515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain.
    Nogami K; Shima M; Giddings JC; Takeyama M; Tanaka I; Yoshioka A
    Int J Hematol; 2007 May; 85(4):317-22. PubMed ID: 17483075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New characteristics of anti-factor VIII inhibitor antibody epitopes and unusual immune responses to Factor VIII.
    Scandella D
    Semin Thromb Hemost; 2002 Jun; 28(3):291-6. PubMed ID: 12098091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-resolution mapping of epitopes on the C2 domain of factor VIII by analysis of point mutants using surface plasmon resonance.
    Nguyen PC; Lewis KB; Ettinger RA; Schuman JT; Lin JC; Healey JF; Meeks SL; Lollar P; Pratt KP
    Blood; 2014 Apr; 123(17):2732-9. PubMed ID: 24591205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitors.
    Meeks SL; Healey JF; Parker ET; Barrow RT; Lollar P
    Blood; 2008 Aug; 112(4):1151-3. PubMed ID: 18495957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in polypeptide-specific factor VIII antigen levels during whole blood clotting.
    Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Sawamoto Y; Kamisue S; Fukui H
    Int J Hematol; 1991 Dec; 54(6):523-30. PubMed ID: 1724392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding to phospholipid protects factor VIII from inactivation by human antibodies.
    Barrowcliffe TW; Kemball-Cook G; Gray E
    J Lab Clin Med; 1983 Jan; 101(1):34-43. PubMed ID: 6401316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action.
    Saenko EL; Ananyeva NM; Kouiavskaia DV; Khrenov AV; Anderson JA; Shima M; Qian J; Scott D
    Haemophilia; 2002 Jan; 8(1):1-11. PubMed ID: 11886458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Acquired inhibitors (autoantibodies) to coagulation factors in non-hemophilic patients].
    Okamura T; Tsuda H
    Rinsho Ketsueki; 1993 May; 34(5):583-7. PubMed ID: 7686235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characterization of the immune response to factor VIII.
    Lollar P
    Vox Sang; 2002 Aug; 83 Suppl 1():403-8. PubMed ID: 12617176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.